Results 11 to 20 of about 10,983,225 (406)
Annual Review of Medicine, 1952 The purpose of this review of ophthalmic articles appearing in the litera ture between September 1950 and September 1951 is to present the salient features of original contributions which either facilitate the understanding of disease processes or bear on medical therapy. Overlapping efforts along similar lines are generally not noted.
Arthur H. Keeney, Irving H. Leopold
openaire +3 more sources
Management of patients with operated refractory neovascular glaucoma (clinical observation)
Медицинский совет, 2021 Introduction. Thrombosis (occlusion) of the central retinal vein (RCVO) and its branches is one of the main causes of loss or significant decrease in vision, including in people of working age, while RCVO is the second most common retinal vascular ...
A. A. Gamidov +2 more
doaj +1 more source
The global prevalence of dry eye disease: A Bayesian view
Ophthalmic & physiological optics, 2021 To provide estimates for the prevalence of dry eye disease globally and in sub‐groups defined by: diagnostic criterion, sex, geographic location and age, using a Bayesian approach.
E. Papas
semanticscholar +1 more source
Management Strategies for Evaporative Dry Eye Disease and Future Perspective
Current Eye Research, 2022 Dry eye disease (DED) is a common disorder that remains challenging from a clinical perspective. Unstable or deficient tear film is a major factor contributing to DED and the inability to resolve the loss of tear film homeostasis that accompanies DED can
M. Rolando, J. Merayo-Lloves
semanticscholar +1 more source
Formulation Considerations for the Management of Dry Eye Disease
Pharmaceutics, 2021 Dry eye disease (DED) is one of the most common ocular surface disorders characterised by a deficiency in quality and/or quantity of the tear fluid. Due to its multifactorial nature involving several inter-related underlying pathologies, it can rapidly ...
Priyanka Agarwal, J. Craig, I. Rupenthal
semanticscholar +1 more source
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
New England Journal of Medicine, 2020 BACKGROUND Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular condition for which no Food and Drug Administration-approved medical therapy is available.
Raymond S. Douglas +22 more
semanticscholar +1 more source
The Relationship Between Dry Eye Disease and Digital Screen Use
Clinical Ophthalmology, 2021 Dry eye disease is characterized by tear film instability that can result in ocular surface damage. Patients with dry eye disease may experience ocular pain/discomfort and visual disturbances that may negatively impact quality of life.
Z. Al-Mohtaseb +4 more
semanticscholar +1 more source
Alternative therapies for dry eye disease
Current Opinion in Ophthalmology, 2021 Purpose of review Dry eye disease (DED) is a multifactorial disease affecting approximately 5–50% of individuals in various populations. Contributors to DED include, but are not limited to, lacrimal gland hypofunction, meibomian gland dysfunction (MGD ...
Rhiya Mittal, Sneh N. Patel, A. Galor
semanticscholar +1 more source
Ocular immunology and inflammation, 2021 Ocular allergy (OA) and dry eye disease (DED) are the most common ocular surface disorders with a potential severe impact on the patient’s quality of life. OA and DED may coexist and have a significant clinical overlap.
A. Leonardi, R. Modugno, Elena Salami
semanticscholar +1 more source